A detailed history of Steward Partners Investment Advisory, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 248,928 shares of ABBV stock, worth $44 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
248,928
Previous 223,894 11.18%
Holding current value
$44 Million
Previous $38.4 Million 28.01%
% of portfolio
0.46%
Previous 0.41%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $4.1 Million - $4.99 Million
25,034 Added 11.18%
248,928 $49.2 Million
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $982,916 - $1.15 Million
6,350 Added 2.92%
223,894 $38.4 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $1.59 Million - $1.82 Million
9,975 Added 4.81%
217,544 $39.6 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $4.61 Million - $5.19 Million
33,489 Added 19.24%
207,569 $32.2 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $555,734 - $643,344
-4,160 Reduced 2.33%
174,080 $25.9 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $217,581 - $270,765
-1,642 Reduced 0.91%
178,240 $24 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $33,549 - $38,637
232 Added 0.13%
179,882 $28.7 Million
Q4 2022

Feb 15, 2023

SELL
$138.31 - $165.87 $170,812 - $204,849
-1,235 Reduced 0.68%
179,650 $29.1 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $334,048 - $383,131
2,489 Added 1.4%
180,885 $24.3 Million
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $2.01 Million - $2.55 Million
-14,589 Reduced 7.56%
178,396 $27.3 Million
Q1 2022

May 02, 2022

SELL
$131.98 - $163.75 $22,040 - $27,346
-167 Reduced 0.09%
192,985 $31.3 Million
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $688,196 - $870,767
6,406 Added 3.43%
193,152 $26.2 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $1.62 Million - $1.84 Million
15,235 Added 8.88%
186,746 $20.1 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $2.31 Million - $2.58 Million
21,997 Added 14.71%
171,511 $19.3 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $2.85 Million - $3.13 Million
27,818 Added 22.86%
149,514 $16.2 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $899,556 - $1.21 Million
11,176 Added 10.11%
121,696 $13 Million
Q3 2020

Oct 30, 2020

BUY
$85.91 - $100.83 $657,297 - $771,450
7,651 Added 7.44%
110,520 $9.68 Million
Q2 2020

Aug 06, 2020

BUY
$73.37 - $98.18 $769,064 - $1.03 Million
10,482 Added 11.35%
102,869 $10.1 Million
Q1 2020

Apr 29, 2020

BUY
$64.5 - $97.79 $353,331 - $535,693
5,478 Added 6.3%
92,387 $7.04 Million
Q4 2019

Jan 17, 2020

BUY
$72.13 - $90.25 $81,651 - $102,163
1,132 Added 1.32%
86,909 $7.69 Million
Q3 2019

Oct 30, 2019

SELL
$62.98 - $75.72 $1.32 Million - $1.58 Million
-20,905 Reduced 19.6%
85,777 $6.5 Million
Q2 2019

Jul 25, 2019

BUY
$65.7 - $83.98 $267,727 - $342,218
4,075 Added 3.97%
106,682 $7.76 Million
Q1 2019

Apr 30, 2019

BUY
$77.14 - $90.79 $403,673 - $475,104
5,233 Added 5.37%
102,607 $8.27 Million
Q4 2018

Jan 15, 2019

SELL
$77.85 - $96.01 $1.32 Million - $1.63 Million
-16,964 Reduced 14.84%
97,374 $8.98 Million
Q3 2018

Oct 23, 2018

BUY
$88.91 - $98.84 $1.99 Million - $2.22 Million
22,427 Added 24.4%
114,338 $10.8 Million
Q2 2018

Jul 20, 2018

BUY
$89.78 - $106.23 $2.69 Million - $3.19 Million
30,014 Added 48.49%
91,911 $8.52 Million
Q1 2018

Apr 20, 2018

SELL
$92.01 - $123.21 $406,592 - $544,464
-4,419 Reduced 6.66%
61,897 $5.86 Million
Q4 2017

Jan 19, 2018

BUY
$89.56 - $98.21 $139,803 - $153,305
1,561 Added 2.41%
66,316 $6.41 Million
Q3 2017

Nov 22, 2017

BUY
$69.85 - $89.22 $219,748 - $280,686
3,146 Added 5.11%
64,755 $5.75 Million
Q2 2017

Nov 22, 2017

BUY
N/A
19,902 Added 47.72%
61,609 $4.47 Million
Q1 2017

Nov 22, 2017

BUY
N/A
22,908 Added 121.86%
41,707 $2.72 Million
Q4 2016

Nov 22, 2017

BUY
N/A
18,799
18,799 $1.18 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.